Risk of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) Among Patients with Type 2 Diabetes Mellitus on Anti-Hyperglycemic Medications.

Oluwasolape OlaworeLindsey E TurnerMichael D EvansSteven G JohnsonJared D HulingCarolyn T BramanteJohn B BuseTil Stürmernull null

Published in: Clinical epidemiology (2024)

The observed estimates in our study are consistent with a reduced risk of PASC among prevalent users of metformin, however the uncertainty of our confidence intervals warrants cautious interpretations of the results. A standardized clinical definition of PASC is warranted for thorough evaluation of the effectiveness of therapies under assessment for the prevention of PASC.

Keyphrases

randomized controlled trial
liver failure
systematic review
drug induced
sars cov
hepatitis b virus
intensive care unit
respiratory syndrome coronavirus
aortic dissection